Search
for
Sort by
Research 211–240 of 1000+
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Hair: What is New in Diagnosis and Management?
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Physiology and Medical Treatments for Alopecia
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
- Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide
- Hair, Hormones, and High-Risk Prostate Cancer
- Update on Frontal Fibrosing Alopecia
- Síndrome postfinasterida y disfunción eréctil. Caso clínico y revisión de la literatura
- Aknede Hormonal Tedavi
- Androgenetic alopecia, hirsutism and hypertrichosis
- Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Enabling finasteride 1 mg users to further improve hair pattern: A randomized, double-blind, placebo-controlled trial of a novel product
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- 5α-Reductase inhibitors in androgenetic alopecia
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Evaluation of 5α-reductase inhibitory activity of certain herbs useful as antiandrogens
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana